Completed
Ixazomib Rollover Study
NCT02924272
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- Appalachian Regional Healthcare Hazard, Kentucky, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States